IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 31 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $10,000 | -73.0% | 42,042 | -67.4% | 0.00% | – |
| Q1 2016 | $37,000 | +640.0% | 129,082 | +1013.4% | 0.00% | – |
| Q2 2015 | $5,000 | -88.4% | 11,593 | -80.2% | 0.00% | – |
| Q4 2014 | $43,000 | +115.0% | 58,599 | +165.0% | 0.00% | – |
| Q3 2014 | $20,000 | -37.5% | 22,115 | -22.6% | 0.00% | – |
| Q2 2014 | $32,000 | +540.0% | 28,587 | +673.0% | 0.00% | – |
| Q1 2014 | $5,000 | -92.8% | 3,698 | -95.0% | 0.00% | – |
| Q4 2013 | $69,000 | +64.3% | 74,704 | +359.9% | 0.00% | – |
| Q3 2013 | $42,000 | – | 16,243 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|